It is established that exogenous IGFBP2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via integrin β1 by promoting ERK phosphorylation and nuclear translocation (Schütt et al., 2004; Yau et al., 2015). Here, IGFBP2 is linked to central nervous system cancer.